Enliven Therapeutics (ELVN) Q1 2020 Earnings

7MayExpected
Q3 2019
Q4 2019
Q1 2020
-4.31
-2.87
-1.44
0

Details

Expected EPS
-0.73
Actual EPS
-4.31
Surprise EPS
-3.58
Surprise Percent
+490.41%

Description

Enliven Therapeutics (ELVN) has reported earnings of -4.31 per share for Q1 2020.

0 Comments

Share your thoughts